Hongzhou Lu

InstitutionFudan University
AddressShanghai
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 75 Covid-19 publications, with a maximum of 8 publications in December 2020
    All Publications
    Bar chart showing 234 publications over 20 distinct years, with a maximum of 47 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Wu N, Dai J, Guo M, Li J, Zhou X, Li F, Gao Y, Qu H, Lu H, Jin J, Li T, Shi L, Wu Q, Tan R, Zhu M, Yang L, Ling Y, Xing S, Zhang J, Yao B, Le S, Gu J, Qin J, Li J, Cheng M, Tan D, Li L, Zhang Y, Zhu Z, Cai J, Song Z, Guo X, Chen LK, Zhu T. Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients. Emerg Microbes Infect. 2021 Dec; 10(1):612-618. PMID: 33703996.
      Citations: 9     Fields:    Translation:HumansCells
    2. Li Q, Wang L, Wang B, Lu H. The COVID-19-designated hospitals in China: preparing for public health emergencies. Emerg Microbes Infect. 2021 Dec; 10(1):998-1001. PMID: 33993856.
      Citations:    Fields:    Translation:HumansPHPublic Health
    3. Meng X, Wang P, Xiong Y, Wu Y, Lin X, Lu S, Li R, Zhao B, Liu J, Zeng S, Zeng L, Wu Y, Lu Y, Zhang J, Liu D, Wang S, Lu H. Safety, tolerability, pharmacokinetic characteristics, and immunogenicity of MW33: a Phase 1 clinical study of the SARS-CoV-2 RBD-targeting monoclonal antibody. Emerg Microbes Infect. 2021 Dec; 10(1):1638-1648. PMID: 34346827.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    4. Li Q, Zhan X, Wang J, Lu H. Considerations and guidance to control the rebound in COVID-19 cases. Biosci Trends. 2021 Nov 21; 15(5):341-344. PMID: 34456212.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    5. Shao Y, Chen J, Lu H. Update: Drug treatment options for coronavirus disease 2019 (COVID-19). Biosci Trends. 2021 Nov 21; 15(5):345-349. PMID: 34433754.
      Citations:    Fields:    Translation:HumansAnimals
    6. Chen J, Liu X, Zhang X, Lin Y, Liu D, Xun J, Wang Z, Gu L, Li Q, Yin D, Yang J, Lu H. Decline in neutralising antibody responses, but sustained T-cell immunity, in COVID-19 patients at 7 months post-infection. Clin Transl Immunology. 2021; 10(7):e1319. PMID: 34336207.
      Citations: 3     
    7. Li M, Wei R, Yang Y, He T, Shen Y, Qi T, Han T, Song Z, Zhu Z, Ma X, Lin Y, Yuan Y, Zhao K, Lu H, Zhou X. Comparing SARS-CoV-2 Testing in Anterior Nasal Vestibular Swabs vs. Oropharyngeal Swabs. Front Cell Infect Microbiol. 2021; 11:653794. PMID: 34307187.
      Citations: 1     Fields:    Translation:Humans
    8. Huang F, Lin M, Sun W, Zhang L, Lu H, Chen WT. Resilience of frontline nurses during the COVID pandemic in China: A qualitative study. Nurs Health Sci. 2021 Sep; 23(3):639-645. PMID: 34110071.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    9. Li Q, Wang J, Lv H, Lu H. Impact of China's COVID-19 prevention and control efforts on outbreaks of influenza. Biosci Trends. 2021 Jul 06; 15(3):192-195. PMID: 34176827.
      Citations:    Fields:    Translation:HumansPHPublic Health
    10. Su J, Lu H. Opportunities and challenges to the use of neutralizing monoclonal antibody therapies for COVID-19. Biosci Trends. 2021 Sep 22; 15(4):205-210. PMID: 34135261.
      Citations:    Fields:    Translation:Humans
    11. Tan Y, Zhang W, Zhu Z, Qiao N, Ling Y, Guo M, Yin T, Fang H, Xu X, Lu G, Zhang P, Yang S, Fu Z, Liang D, Xie Y, Zhang R, Jiang L, Yu S, Lu J, Jiang F, Chen J, Xiao C, Wang S, Chen S, Bian XW, Lu H, Liu F, Chen S. Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19. Cell Discov. 2021 Jun 08; 7(1):42. PMID: 34103487.
      Citations: 4     
    12. Wang Z, Chen J, Zhu C, Liu L, Qi T, Shen Y, Zhang Y, Xu L, Li T, Qian Z, Steinhart CR, Lu H. Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients. Front Immunol. 2021; 12:568789. PMID: 34149679.
      Citations: 1     Fields:    Translation:HumansCells
    13. Sun W, Chen WT, Zhang Q, Ma S, Huang F, Zhang L, Lu H. Post-Traumatic Growth Experiences among COVID-19 Confirmed Cases in China: A Qualitative Study. Clin Nurs Res. 2021 09; 30(7):1079-1087. PMID: 34018405.
      Citations: 2     Fields:    Translation:Humans
    14. Li Q, Wang J, Zhou X, Lu H, Lu M, Huang L. Case Report: Viral Pneumonia Could Prompt the Advancement of Immune-Mediated Liver Disease. Front Med (Lausanne). 2021; 8:582620. PMID: 34079806.
      Citations:    
    15. Feng Y, Zeng D, Hu L, Yang Y, Song S, Shi Y, Xu J, Guo W, Ling Y, Qi T, Wu Q, Li F, Cheng J, Lu H. Case report: histopathology and molecular pathology analysis on enteric tissue of a COVID-19 patient. Diagn Pathol. 2021 May 05; 16(1):40. PMID: 33952310.
      Citations: 1     Fields:    Translation:HumansCells
    16. Hui J, Li H, Gao F, Shang Q, Wang J, Lu H. Combating COVID-19 as a designated hospital: Experience from Shanghai, China. Glob Health Med. 2021 Apr 30; 3(2):112-114. PMID: 33937575.
      Citations:    
    17. Lv Y, Ma Y, Si Y, Zhu X, Zhang L, Feng H, Tian D, Liao Y, Liu T, Lu H, Ling Y. Rapid SARS-CoV-2 antigen detection potentiates early diagnosis of COVID-19 disease. Biosci Trends. 2021 May 11; 15(2):93-99. PMID: 33776018.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    18. Zhang L, Chai L, Zhao Y, Wang L, Sun W, Lu L, Lu H, Zhang J. Burnout in nurses during the COVID-19 pandemic in China: New challenges for public health. Biosci Trends. 2021 May 11; 15(2):129-131. PMID: 33776019.
      Citations:    Fields:    Translation:HumansPHPublic Health
    19. Chen J, Lu H. New challenges to fighting COVID-19: Virus variants, potential vaccines, and development of antivirals. Biosci Trends. 2021 May 11; 15(2):126-128. PMID: 33746183.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    20. Li S, Wu B, Ling Y, Guo M, Qin B, Ren X, Wang C, Yang H, Chen L, Liao Y, Liu Y, Peng X, Xu C, Wang Z, Shen Y, Chen J, Liu L, Niu B, Zhu M, Liu L, Li F, Zhu T, Zhu Z, Zhou X, Lu H. Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients. Front Immunol. 2021; 12:625881. PMID: 33717140.
      Citations: 2     Fields:    Translation:HumansCells
    21. Li A, Ling Y, Song Z, Cheng X, Ding L, Jiang R, Fu W, Liu Y, Hu H, Yuan S, Chen J, Zhu C, Fan J, Wang J, Jin Y, Zhang M, Zhu L, Sun P, Zhang L, Qin R, Zhang W, Qiu C, Shen Y, Zhang L, Shi Z, Zhao C, Zhu T, Lu H, Zhang X, Xu J. Correlation Between Early Plasma Interleukin 37 Responses With Low Inflammatory Cytokine Levels and Benign Clinical Outcomes in Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J Infect Dis. 2021 02 24; 223(4):568-580. PMID: 33197260.
      Citations: 4     Fields:    Translation:HumansAnimals
    22. Shi W, Peng X, Liu T, Cheng Z, Lu H, Yang S, Zhang J, Wang M, Gao Y, Shi Y, Zhang Z, Shan F. A deep learning-based quantitative computed tomography model for predicting the severity of COVID-19: a retrospective study of 196 patients. Ann Transl Med. 2021 Feb; 9(3):216. PMID: 33708843.
      Citations: 7     
    23. Xing Y, Zhao B, Yin L, Guo M, Shi H, Zhu Z, Zhang L, He J, Ling Y, Gao M, Lu H, Mao E, Zhang L. Vitamin C supplementation is necessary for patients with coronavirus disease: An ultra-high-performance liquid chromatography-tandem mass spectrometry finding. J Pharm Biomed Anal. 2021 Mar 20; 196:113927. PMID: 33549875.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    24. Sun W, Zhou Y, Chen WT, Huang F, Sun M, Shen L, Gao Y, Zhang Q, Ma S, Shiu C, Zhang L, Lu H. Disclosure experience among COVID-19-confirmed patients in China: A qualitative study. J Clin Nurs. 2021 Mar; 30(5-6):783-792. PMID: 33349988.
      Citations: 1     Fields:    Translation:Humans
    25. Chen J, Liu D, Yin L, Zhang L, Lu H. Can we use hydroxychloroquine to treat COVID-19 now? Int J Antimicrob Agents. 2021 Jan; 57(1):106173. PMID: 33408016.
      Citations: 1     Fields:    Translation:Humans
    26. Li M, Yang Y, He T, Wei R, Shen Y, Qi T, Han T, Song Z, Zhu Z, Ma X, Zhao J, Lin Y, Shen Y, Yang W, Zhao K, Lu H, Zhou X. Detection of SARS-CoV-2 in the ocular surface in different phases of COVID-19 patients in Shanghai, China. Ann Transl Med. 2021 Jan; 9(2):100. PMID: 33569402.
      Citations: 1     
    27. Li Q, Wang J, Tang Y, Lu H. Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19. Drug Discov Ther. 2021; 15(3):118-123. PMID: 34234059.
      Citations:    Fields:    Translation:Humans
    28. Li Q, Lu H. Latest updates on COVID-19 vaccines. Biosci Trends. 2021 Jan 23; 14(6):463-466. PMID: 33390384.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    29. Su Y, Ling Y, Ma Y, Tao L, Miao Q, Shi Q, Pan J, Lu H, Hu B. Efficacy of early hydroxychloroquine treatment in preventing COVID-19 pneumonia aggravation, the experience from Shanghai, China. Biosci Trends. 2021 Jan 23; 14(6):408-414. PMID: 33342929.
      Citations: 2     Fields:    Translation:Humans
    30. Bao Y, Ling Y, Chen YY, Tian D, Zhao GP, Zhang XH, Hang H, Li Y, Su B, Lu HZ, Xu J, Wang Y. Dynamic anti-spike protein antibody profiles in COVID-19 patients. Int J Infect Dis. 2021 Feb; 103:540-548. PMID: 33310028.
      Citations: 5     Fields:    Translation:Humans
    31. Song F, Shi N, Shan F, Zhang Z, Shen J, Lu H, Ling Y, Jiang Y, Shi Y. Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology. 2020 Dec; 297(3):E346. PMID: 33196374.
      Citations: 14     Fields:    
    32. Yi Z, Ling Y, Zhang X, Chen J, Hu K, Wang Y, Song W, Ying T, Zhang R, Lu H, Yuan Z. Functional mapping of B-cell linear epitopes of SARS-CoV-2 in COVID-19 convalescent population. Emerg Microbes Infect. 2020 Dec; 9(1):1988-1996. PMID: 32844713.
      Citations: 16     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    33. Liu XH, Lu SH, Chen J, Xia L, Yang ZG, Charles S, Yang Y, Lin Y, Lu HZ. Clinical characteristics of foreign-imported COVID-19 cases in Shanghai, China. Emerg Microbes Infect. 2020 Dec; 9(1):1230-1232. PMID: 32515651.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    34. Li T, Lu H, Zhang W. Clinical observation and management of COVID-19 patients. Emerg Microbes Infect. 2020 Dec; 9(1):687-690. PMID: 32208840.
      Citations: 113     Fields:    Translation:HumansCellsPHPublic Health
    35. Shen Y, Zheng F, Sun D, Ling Y, Chen J, Li F, Li T, Qian Z, Zhang Y, Xu Q, Liu L, Huang Q, Shan F, Xu L, Wu J, Zhu Z, Song Z, Li S, Shi Y, Zhang J, Wu X, Mendelsohn JB, Zhu T, Lu H. Epidemiology and clinical course of COVID-19 in Shanghai, China. Emerg Microbes Infect. 2020 Dec; 9(1):1537-1545. PMID: 32573353.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    36. Dai Z, Zeng D, Cui D, Wang D, Feng Y, Shi Y, Zhao L, Xu J, Guo W, Yang Y, Zhao X, Li D, Zheng Y, Wang A, Wu M, Song S, Lu H. Prediction of COVID-19 Patients at High Risk of Progression to Severe Disease. Front Public Health. 2020; 8:574915. PMID: 33330318.
      Citations: 3     Translation:Humans
    37. Zhao B, Ling Y, Li J, Peng Y, Huang J, Wang Y, Qu H, Gao Y, Li Y, Hu B, Lu S, Lu H, Zhang W, Mao E. Beneficial aspects of high dose intravenous vitamin C on patients with COVID-19 pneumonia in severe condition: a retrospective case series study. Ann Palliat Med. 2021 Feb; 10(2):1599-1609. PMID: 33222462.
      Citations: 7     Fields:    Translation:Humans
    38. Stratton CW, Tang YW, Lu H. Pathogenesis-directed therapy of 2019 novel coronavirus disease. J Med Virol. 2021 03; 93(3):1320-1342. PMID: 33073355.
      Citations: 13     Fields:    Translation:Humans
    39. Zhu H, Lu H. The development of a quarantine strategy is an important path to a normalized response to COVID-19. Biosci Trends. 2020 Nov 04; 14(5):396-398. PMID: 33100292.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    40. Xia L, Shi Y, Su J, Friedemann T, Tao Z, Lu Y, Ling Y, Lv Y, Zhao R, Geng Z, Cui X, Lu H, Schröder S. Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study. Phytomedicine. 2021 May; 85:153390. PMID: 33158717.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    41. Guo L, Xiong W, Liu D, Feng Y, Wang P, Dong X, Chen R, Wang Y, Zhang L, Huang J, Summah HD, Lu F, Xie Y, Lin H, Yan J, Lu H, Zhou M, Qu J. The mNCP-SPI Score Predicting Risk of Severe COVID-19 among Mild-Pneumonia Patients on Admission. Infect Drug Resist. 2020; 13:3593-3600. PMID: 33116679.
      Citations: 4     
    42. Tan Y, Liu F, Xu X, Ling Y, Huang W, Zhu Z, Guo M, Lin Y, Fu Z, Liang D, Zhang T, Fan J, Xu M, Lu H, Chen S. Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection. Front Med. 2020 Dec; 14(6):746-751. PMID: 33017040.
      Citations: 19     Fields:    Translation:HumansCells
    43. Guo H, Zhang Z, Zhang Y, Liu Y, Wang J, Qian Z, Zou Y, Lu H. Analysis of liver injury factors in 332 patients with COVID-19 in Shanghai, China. Aging (Albany NY). 2020 Oct 01; 12(19):18844-18852. PMID: 33001040.
      Citations: 4     Fields:    
    44. Wu F, Liu M, Wang A, Lu L, Wang Q, Gu C, Chen J, Wu Y, Xia S, Ling Y, Zhang Y, Xun J, Zhang R, Xie Y, Jiang S, Zhu T, Lu H, Wen Y, Huang J. Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China. JAMA Intern Med. 2020 10 01; 180(10):1356-1362. PMID: 32808970.
      Citations: 85     Fields:    Translation:HumansCellsPHPublic Health
    45. Fu W, Liu Y, Liu L, Hu H, Cheng X, Liu P, Song Z, Zha L, Bai S, Xu T, Yuan S, Lu F, Shang Z, Zhao Y, Wang J, Zhao J, Ding L, Chen J, Zhang L, Zhu T, Zhang X, Lu H, Xu J. An open-label, randomized trial of the combination of IFN-? plus TFF2 with standard care in the treatment of patients with moderate COVID-19. EClinicalMedicine. 2020 Oct; 27:100547. PMID: 32984784.
      Citations: 9     
    46. Jiang X, Wang X, Liu B, Ding H, Jiang M, Yang Z, Dai Y, Ding D, Yu H, Zhang S, Liu J, Sha M, Lui C, Qiu Y, Lu H, Hu Q. CCL28 mucosal expression in SARS-CoV-2-infected patients with diarrhea in relation to disease severity. J Infect. 2021 01; 82(1):e19-e21. PMID: 32871180.
      Citations: 2     Fields:    Translation:HumansCells
    47. Chen L, Huang S, Yang J, Cheng X, Shang Z, Lu H, Cheng J. Clinical characteristics in patients with SARS-CoV-2/HBV co-infection. J Viral Hepat. 2020 12; 27(12):1504-1507. PMID: 32668494.
      Citations: 17     Fields:    Translation:Humans
    48. Fu W, Liu Y, Xia L, Li M, Song Z, Hu H, Yang Z, Wang L, Cheng X, Wang M, Jiang R, Liu L, Mao X, Chen J, Ling Y, Zhang L, Yan J, Shan F, Steinhart C, Zhang X, Zhu T, Xu J, Lu H. A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-? plus TFF2 in patients with moderate COVID-19. EClinicalMedicine. 2020 Aug; 25:100478. PMID: 32838238.
      Citations: 7     
    49. Lu H, Stratton CW, Tang YW. An evolving approach to the laboratory assessment of COVID-19. J Med Virol. 2020 10; 92(10):1812-1817. PMID: 32347966.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    50. Xia L, Chen J, Friedemann T, Yang Z, Ling Y, Liu X, Lu S, Li T, Song Z, Huang W, Lu Y, Schröder S, Lu H. The Course of Mild and Moderate COVID-19 Infections-The Unexpected Long-Lasting Challenge. Open Forum Infect Dis. 2020 Sep; 7(9):ofaa286. PMID: 32929402.
      Citations: 5     
    51. Feng M, Chen J, Xun J, Dai R, Zhao W, Lu H, Xu J, Chen L, Sui G, Cheng X. Development of a Sensitive Immunochromatographic Method Using Lanthanide Fluorescent Microsphere for Rapid Serodiagnosis of COVID-19. ACS Sens. 2020 08 28; 5(8):2331-2337. PMID: 32660240.
      Citations: 12     Fields:    Translation:HumansPHPublic Health
    52. Xie G, Ding F, Han L, Yin D, Lu H, Zhang M. The role of peripheral blood eosinophil counts in COVID-19 patients. Allergy. 2021 02; 76(2):471-482. PMID: 32562554.
      Citations: 41     Fields:    Translation:HumansCells
    53. Mei X, Zhang Y, Zhu H, Ling Y, Zou Y, Zhang Z, Guo H, Liu Y, Cheng X, Liu M, Huang W, Wang J, Yi Z, Qian Z, Lu H. Observations about symptomatic and asymptomatic infections of 494 patients with COVID-19 in Shanghai, China. Am J Infect Control. 2020 09; 48(9):1045-1050. PMID: 32645475.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    54. Chen J, Xia L, Liu L, Xu Q, Ling Y, Huang D, Huang W, Song S, Xu S, Shen Y, Lu H. Antiviral Activity and Safety of Darunavir/Cobicistat for the Treatment of COVID-19. Open Forum Infect Dis. 2020 Jul; 7(7):ofaa241. PMID: 32671131.
      Citations: 33     
    55. Qiu C, Cui C, Hautefort C, Haehner A, Zhao J, Yao Q, Zeng H, Nisenbaum EJ, Liu L, Zhao Y, Zhang D, Levine CG, Cejas I, Dai Q, Zeng M, Herman P, Jourdaine C, de With K, Draf J, Chen B, Jayaweera DT, Denneny JC, Casiano R, Yu H, Eshraghi AA, Hummel T, Liu X, Shu Y, Lu H. Olfactory and Gustatory Dysfunction as an Early Identifier of COVID-19 in Adults and Children: An International Multicenter Study. Otolaryngol Head Neck Surg. 2020 10; 163(4):714-721. PMID: 32539586.
      Citations: 49     Fields:    Translation:HumansCellsPHPublic Health
    56. Meng X, Ling Y, Zhang L, Zhang Q, Dong P, Zhu T, Lu H. Potential for jaktinib hydrochloride to treat cytokine storms in patients with COVID-19. Biosci Trends. 2020 Jul 17; 14(3):161-167. PMID: 32536632.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    57. Chen J, Lu H, Melino G, Boccia S, Piacentini M, Ricciardi W, Wang Y, Shi Y, Zhu T. COVID-19 infection: the China and Italy perspectives. Cell Death Dis. 2020 06 08; 11(6):438. PMID: 32513951.
      Citations: 26     Fields:    Translation:HumansCellsPHPublic Health
    58. Yang S, Zhang Y, Shen J, Dai Y, Ling Y, Lu H, Zhang R, Ding X, Qi H, Shi Y, Zhang Z, Shan F. Clinical Potential of UTE-MRI for Assessing COVID-19: Patient- and Lesion-Based Comparative Analysis. J Magn Reson Imaging. 2020 08; 52(2):397-406. PMID: 32491257.
      Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
    59. Feng Y, Ling Y, Bai T, Xie Y, Huang J, Li J, Xiong W, Yang D, Chen R, Lu F, Lu Y, Liu X, Chen Y, Li X, Li Y, Summah HD, Lin H, Yan J, Zhou M, Lu H, Qu J. COVID-19 with Different Severities: A Multicenter Study of Clinical Features. Am J Respir Crit Care Med. 2020 06 01; 201(11):1380-1388. PMID: 32275452.
      Citations: 279     Fields:    Translation:HumansCellsPHPublic Health
    60. Liu Y, Mao B, Liang S, Yang JW, Lu HW, Lu HW, Chai YH, Wang L, Zhang L, Li QH, Zhao L, He Y, Gu XL, Ji XB, Li L, Jie ZJ, Li Q, Li XY, Lu HZ, Zhang WH, Song YL, Qu JM, Xu JF. Association between age and clinical characteristics and outcomes of COVID-19. Eur Respir J. 2020 05; 55(5). PMID: 32312864.
      Citations: 101     Fields:    Translation:HumansCellsPHPublic Health
    61. Chen J, Liu D, Liu L, Liu P, Xu Q, Xia L, Ling Y, Huang D, Song S, Zhang D, Qian Z, Li T, Shen Y, Lu H. [A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25; 49(2):215-219. PMID: 32391667.
      Citations: 253     Fields:    Translation:HumansCellsPHPublic Health
    62. Li Q, Zhang J, Ling Y, Li W, Zhang X, Lu H, Chen L. A simple algorithm helps early identification of SARS-CoV-2 infection patients with severe progression tendency. Infection. 2020 Aug; 48(4):577-584. PMID: 32440918.
      Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
    63. Zhang X, Tan Y, Ling Y, Lu G, Liu F, Yi Z, Jia X, Wu M, Shi B, Xu S, Chen J, Wang W, Chen B, Jiang L, Yu S, Lu J, Wang J, Xu M, Yuan Z, Zhang Q, Zhang X, Zhao G, Wang S, Chen S, Lu H. Viral and host factors related to the clinical outcome of COVID-19. Nature. 2020 07; 583(7816):437-440. PMID: 32434211.
      Citations: 268     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    64. Mao B, Liu Y, Chai YH, Jin XY, Lu HW, Lu HW, Yang JW, Gao XW, Song XL, Bao H, Wang A, Gu WC, Zhao L, Pan JP, Li F, Zhang TF, Qian YC, Du CL, Ding W, Tu CL, Chu DJ, Li C, Ye L, Luo Y, Zheng CX, Yu RH, Qiu ZM, Cao HF, Ren JW, Zhao JY, Wang CH, Lu HZ, Li J, Hu Y, Liang S, Jie ZJ, Qu JM, Xu JF. Assessing risk factors for SARS-CoV-2 infection in patients presenting with symptoms in Shanghai, China: a multicentre, observational cohort study. Lancet Digit Health. 2020 06; 2(6):e323-e330. PMID: 32501440.
      Citations: 22     Translation:Humans
    65. Cui C, Yao Q, Zhang D, Zhao Y, Zhang K, Nisenbaum E, Cao P, Zhao K, Huang X, Leng D, Liu C, Li N, Luo Y, Chen B, Casiano R, Weed D, Sargi Z, Telischi F, Lu H, Denneny JC, Shu Y, Liu X. Approaching Otolaryngology Patients During the COVID-19 Pandemic. Otolaryngol Head Neck Surg. 2020 07; 163(1):121-131. PMID: 32396445.
      Citations: 22     Fields:    Translation:HumansCellsPHPublic Health
    66. Ling Y, Xu SB, Lin YX, Tian D, Zhu ZQ, Dai FH, Wu F, Song ZG, Huang W, Chen J, Hu BJ, Wang S, Mao EQ, Zhu L, Zhang WH, Lu HZ. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl). 2020 May 05; 133(9):1039-1043. PMID: 32118639.
      Citations: 324     Fields:    Translation:HumansCellsPHPublic Health
    67. Yang S, Shi Y, Lu H, Xu J, Li F, Qian Z, Jiang Y, Hua X, Ding X, Song F, Shen J, Lu Y, Shan F, Zhang Z. Clinical and CT features of early stage patients with COVID-19: a retrospective analysis of imported cases in Shanghai, China. Eur Respir J. 2020 04; 55(4). PMID: 32217649.
      Citations: 20     Fields:    Translation:HumansCellsPHPublic Health
    68. Zou Y, Guo H, Zhang Y, Zhang Z, Liu Y, Wang J, Lu H, Qian Z. Analysis of coagulation parameters in patients with COVID-19 in Shanghai, China. Biosci Trends. 2020 Sep 21; 14(4):285-289. PMID: 32350161.
      Citations: 37     Fields:    Translation:HumansCellsPHPublic Health
    69. Liu F, Zhang Q, Huang C, Shi C, Wang L, Shi N, Fang C, Shan F, Mei X, Shi J, Song F, Yang Z, Ding Z, Su X, Lu H, Zhu T, Zhang Z, Shi L, Shi Y. CT quantification of pneumonia lesions in early days predicts progression to severe illness in a cohort of COVID-19 patients. Theranostics. 2020; 10(12):5613-5622. PMID: 32373235.
      Citations: 76     Fields:    Translation:HumansCellsPHPublic Health
    70. Chen J, Qi T, Liu L, Ling Y, Qian Z, Li T, Li F, Xu Q, Zhang Y, Xu S, Song Z, Zeng Y, Shen Y, Shi Y, Zhu T, Lu H. Clinical progression of patients with COVID-19 in Shanghai, China. J Infect. 2020 05; 80(5):e1-e6. PMID: 32171869.
      Citations: 288     Fields:    Translation:HumansCellsPHPublic Health
    71. Lu H, Stratton CW, Tang YW. The Wuhan SARS-CoV-2-What's next for China. J Med Virol. 2020 06; 92(6):546-547. PMID: 32115732.
      Citations: 19     Fields:    Translation:HumansCellsPHPublic Health
    72. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol. 2020 04; 92(4):401-402. PMID: 31950516.
      Citations: 857     Fields:    Translation:HumansAnimals
    73. Song F, Shi N, Shan F, Zhang Z, Shen J, Lu H, Ling Y, Jiang Y, Shi Y. Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology. 2020 04; 295(1):210-217. PMID: 32027573.
      Citations: 400     Fields:    Translation:HumansCells
    74. Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends. 2020 Mar 16; 14(1):69-71. PMID: 31996494.
      Citations: 377     Fields:    Translation:HumansCells
    75. Xie L, Wu Q, Lin Q, Liu X, Lin W, Hao S, Hu W, Xiang G, Lu H, Li S. Dysfunction of adaptive immunity is related to severity of COVID-19: a retrospective study. Ther Adv Respir Dis. 2020 Jan-Dec; 14:1753466620942129. PMID: 32684101.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    Lu's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (439)
    Explore
    _
    Co-Authors (679)
    Explore
    _
    Similar People (60)
    Explore
    _